Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Bayer AG and plaintiffs lawyers have reached a $1.6 billion proposed agreement to resolve U.S. injury claims involving its female sterilization device Essure. The settlement includes in all jurisdictions with high volumes of Essure litigation, such as the coordinated cases in California and lawsuits in the U.S. District Court for the Eastern District of Pennsylvania, Bayer reports, resolving about 90% of the nearly 39,000 total claims that the implant caused side effects such as hair and tooth loss, chronic bleeding, miscarriages and death of both Essure recipients and their infants.

“With the settlements, Bayer resolves virtually all of the U.S. Essure litigation so that the company can focus on its commitment to women’s health, where it has long been a leader, without the distractions and uncertainties associated with this litigation,”Bayer said in a statement. The  company stated in a news release that there is no admission of wrongdoing or liability by Bayer in the settlement agreements.

Plaintiffs attorneys from Motley Rice; Fibich Leebron Copeland Briggs; Wexler Wallace; and Grant & Eisenhofer primarily negotiated for plaintiffs in the resolution, with DLA Piper largely stepping in for Bayer, according to a spokesperson from Motley Rice. Motley Rice’s Fidelma Fitzpatrick, who is lead counsel of the plaintiffs’ executive committee for the California Joint Council Coordinated Proceedings and helped to negotiate the deal, said the proposed settlement would provide expedited relief to thousands of women. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Alaina Lancaster

Alaina Lancaster, based in San Francisco, covers disruptive trends and technologies shaping the future of law. She authors the weekly legal futurist newsletter What's Next. Contact her at [email protected]. On Twitter: @a_lancaster3

More from this author

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

Insurance Coverage DisputesBook

A comprehensive guide to the issues that can arise at every stage of a coverage dispute, from the initial inquiry to complex questions of law, evidence, procedure and st...

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.